ATX 4.69% 6.1¢ amplia therapeutics limited

Ann: Update on ACCENT Trial in Pancreatic Cancer, page-32

  1. 406 Posts.
    lightbulb Created with Sketch. 18
    I liked the efficacy slide. imagine how it would look with 100% of the recipients on full dose

    also good to see that they are seeking pharmaceutical partners to invest in next stage of trials. if successful, it will reduce dilution and validate potential. won't happen until mid next year when full results are in.
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.1¢
Change
-0.003(4.69%)
Mkt cap ! $16.56M
Open High Low Value Volume
6.4¢ 6.4¢ 6.1¢ $14.71K 240.6K

Buyers (Bids)

No. Vol. Price($)
1 6872 6.1¢
 

Sellers (Offers)

Price($) Vol. No.
6.4¢ 11099 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.